SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (1029)7/24/1997 10:20:00 PM
From: JOHN W.   of 6136
 
Peter, these critics and yourself need to study more about antiretroviral therapy. Viracept's diarrhea has been completely overblown, and is only important for citics of the company's stock price.
1) For the vast majority of these patients, over the counter medication
eliminates diarrhea. Severe diarrhea is caused by other treatments that can't be as easily controlled. What is the PI? Crixivan!

2) People are distorting information on drugs which could save lives, just to make money. God forgive them.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News